FDA
approval
· 2018-02-12
FDA Approved: SYMDEKO — Original Application (Vertex Pharmaceuticals Incorporated)
Summary
FDA approved SYMDEKO (tezacaftor and ivacaftor) as the original application for the treatment of cystic fibrosis. This action represents the original approval o…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SYMDEKO (TEZACAFTOR AND IVACAFTOR)